Ligand Pharmaceuticals | LGND - 销售成本



金融业
股票价格
USD
资产
USD 1.53B
现金及等价物
USD 115.08M
销售成本
USD 11.37M
流动资产
USD 865.42M
流动负债
USD 40.67M
债务
USD 451.49M
EBIT
USD 60.33M
EBITDA
USD 66.78M
员工
68
EPS每股收益
USD 1.63
股本和储备
USD 997.32M
销售毛利
USD 48.45M
债务利息支出
USD 1.79M
利息收入
USD 6.39M
贷款资金
USD 446.19M
市值
USD 5.35B
净收入
USD -13.35M
营业费用
USD 34.35M
营业利润
USD 60.33M
普通股股本
USD 19.66M
PE价格收益
56.5
税前利润
USD 56.78M
销售收入
USD 51.72M
销售和管理费用
USD 20.84M
股票
USD 13.27M
贸易债权人
USD 37.11M
应收帐款人
USD 54.8M


销售成本 更改 日
Agenus USD 642K 399K 2025-09
Amgen USD 1.6B 187M 2026-03
Anika Therapeutics USD 11.44M 797K 2025-12
Baxter International USD 1.81B 587M 2026-03
Bristol-Myers Squibb USD 3.86B 1.07B 2026-03
Eli Lilly USD 3.58B 205M 2026-03
Enviri Corporation USD 472M 17.65M 2025-12
Gilead Sciences USD 1.44B 174M 2026-03
GlaxoSmithKline GBP 1.88B 736M 2026-03
Glaxosmithkline GBP 1.88B 1.6B 2026-03
Heron Therapeutics USD 11.12M 795K 2025-12
Insmed USD 49.5M 3.34M 2026-03
Intrexon USD 1.01M 344K 2024-06
Ionis Pharmaceuticals USD 3M 5M 2026-03
Karyopharm Therapeutics USD 1.48M 35.95M 2025-12
Ligand Pharmaceuticals USD 11.37M 8.38M 2026-03
MacroGenics USD 9.53M 585K 2026-03
Merck USD 2.94B 380M 2026-03
Pacira USD 50.74M 3.89M 2026-03
Pfizer USD 4.59B 1.7B 2026-03
Rigel Pharmaceuticals USD 8.03M 5.22M 2024-09
Sangamo BioSciences 2.42M 1.11M 2024-06
Veracyte USD 38.49M 794K 2026-03